Form 4: Oscar Health Legal Chief Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


Oscar Health's Chief Legal Officer, Adam McAnaney, sold 1,852 shares of Class A Common Stock to cover tax withholding obligations from vested equity awards.

Summary

  • Adam McAnaney, Chief Legal Officer of Oscar Health, Inc. (OSCR), sold 1,852 shares of Class A Common Stock.
  • The transaction occurred on December 2, 2025, at a weighted average price of $16.59 per share, with prices ranging from $16.37 to $16.78.
  • The sale was executed under a Rule 10b5-1 plan established on August 8, 2025.
  • The purpose of the sale was to satisfy tax withholding obligations related to the vesting of previously granted equity awards.
  • Following this transaction, McAnaney beneficially owns 179,241 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider sale for tax purposes under a Rule 10b5-1 plan, which is a neutral event with no significant positive or negative implications for the company's operational or financial health.

Positives

  • The sale was pre-planned under a Rule 10b5-1 plan, indicating a lack of discretionary timing and reducing concerns about opportunistic insider trading.
  • The sale was explicitly for tax withholding obligations, which is a common and expected event for executives receiving equity compensation.

Negatives

  • An insider sale, even for tax purposes, reduces the officer's direct equity stake in the company.

Future Outlook

NA

Industry Context

This is a routine insider transaction filing and does not provide specific industry context or trends. It reflects an individual executive's compensation-related stock activity within the healthcare technology sector.

Stakeholder Impact

  • Shareholders: Minimal direct impact. A small reduction in insider ownership, but for a routine tax purpose, which is generally not viewed negatively.
  • Employees, Customers, Suppliers, Creditors: No direct impact from this specific filing.

Key Dates

DateDescription
2025-08-08Date Rule 10b5-1 instruction letter was entered into.
2025-12-02Date of transaction (sale of shares).
2025-12-04Date of filing signature.

Recommendation

hold

This Form 4 reports a routine, pre-planned insider sale by the Chief Legal Officer to cover tax obligations from vested equity awards. Such transactions are common and do not typically signal a change in management's confidence or the company's fundamentals. Therefore, it provides no new information to alter an existing investment thesis, warranting a 'hold' recommendation based solely on this filing.

Keywords

Oscar Health, OSCR, Adam McAnaney, Chief Legal Officer, Form 4, Insider Sale, Equity Awards, Tax Withholding, Rule 10b5-1, Stock Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.